SHP2 inhibition as the backbone of targeted therapy combinations for the treatment of cancers driven by oncogenic mutations in the RAS pathway

Jacqueline A. M. Smith, Mallika Singh, Robert J. Nichols, Elena S. Koltun, Yu C. Yang, David P. Wildes, Carlos Stahlhut, Dong Lee, Chris J. Schulze, Denise Reyes, Abby Marquez, Grace J. Lee, Shaoling Li, Christophe Marcireau, Laurent Debussche, Mark A. Goldsmith, Zhengping Wang, Adrian L. Gill, Steve M. Kelsey


American Association for Cancer Research Annual Meeting 2020, Virtual Meeting II; June 22-24, 2020.  Poster 1943.


Return to Media Home